DC Capital
Long/short equity, special situations, event-driven, arbitrage

Santarus' Impressive Margins, High ROIC, And Low Financial Risk Boost Upside Potential

Santarus, Inc. (NASDAQ:SNTS) has provided investors with an impressive return over the last year. After having increasing 100% YTD, its 30-day RSI still remains low at only 41.5, which is a good indication that its common stock is no where near being overbought. Investors who have already had the luxury of capitalizing on these returns, may want continue holding, as there is plenty of upside potential to make initiating a position worthwhile for new investors. From an operational standpoint, Santarus is in an excellent position to continue gaining further market share within its niche segment of the bio-pharmaceutical industry. Industry peers are always a competitive threat for this industry in particular, however high barriers to entry surrounding Santarus'...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details